Abrocitinib
1 NDC across 1 manufacturer|0 Generic,1 Brand
Abrocitinib is used to treat atopic dermatitis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Jan 14, 2022. In 2024, Medicare Part D spent $17 million on Abrocitinib across 2,728 claims for 536 beneficiaries.
Abrocitinib is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $197.09 to $197.09 per EA. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
1
0G / 1B
Manufacturers
1
competing in market
Price Spread
$197.09 – $197.09
per EA
7d Activity
avg +0.1% WoW · of 1 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing ABROCITINIB
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
CIBINQO 100 MG TABLET | $197.0924 per EA | +0.15% |
Frequently Asked Questions
What is Abrocitinib used to treat?
Abrocitinib is used to treat atopic dermatitis, per the National Library of Medicine's MED-RT classification.
How much does Medicare spend on Abrocitinib?
In 2024, Medicare Part D spent $17 million on Abrocitinib across 2,728 claims for 536 beneficiaries.
How many Abrocitinib products are on the market?
The Abrocitinib drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.
What is the price range for Abrocitinib?
NADAC reference prices for Abrocitinib range from $197.0924 to $197.0924 per EA.
Which manufacturers make Abrocitinib?
1 manufacturer lists Abrocitinib in NADAC. Ranked by number of NDCs, the largest are Pfizer Inc. (1).
How has the price of Abrocitinib changed recently?
Over the past 7 days, 1 Abrocitinib NDC rose and 0 fell, with a market-wide average change of +0.1%.